EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in the clinical spectrum and pathomechanisms associated with X-linked myopathy with excessive autophagy and other VMA21 -related disorders

Ilaria Cocchiararo, Perrine Castets

Journal of Neuromuscular Diseases · 2025

DOI: 10.1177/22143602251314767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuromuscular Diseases, 2025. Verfasst von Ilaria Cocchiararo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Autophagy, Vacuolar Proton-Translocating ATPases, Genetic Diseases, X-Linked, Muscular Diseases. Die Arbeit nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-linked myopathy with excessive autophagy (XMEA) is a rare neuromuscular disorder caused by mutations in the VMA21 gene, encoding a chaperone protein present in the endoplasmic reticulum (ER). In yeast and human, VMA21 has been shown to chaperone the assembly of the vacuolar (v)-ATPase proton pump required for the acidification of lysosomes and other organelles. In line with this, VMA21 deficiency in XMEA impairs autophagic degradation steps, which would be key in XMEA pathogenesis. Recent years have witnessed a surge of interest in VMA21, with the identification of novel mutations causing a congenital disorder of glycosylation (CDG) with liver affection, and its potent implication in cancer predisposition. With this, VMA21 deficiency has been further linked to defective glycosylation, lipid metabolism dysregulation and ER stress. Moreover, the identification of two VMA21 isoforms, namely VMA21-101 and VMA21-120, has opened novel avenues regarding the pathomechanisms leading to XMEA and VMA21-CDG. In this review, we discuss recent advances on the clinical spectrum associated with VMA21 deficiency and on the pathophysiological roles of VMA21.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyVacuolar Proton-Translocating ATPasesGenetic Diseases, X-LinkedMuscular DiseasesHumansMutationAnimals

Stichwörter der Autor:innen

VMA21X-linked myopathy with excessive autophagyautophagic vacuolar myopathies

Substanzen

VMA21 protein, humanVacuolar Proton-Translocating ATPases

Autor:innen und Institutionen

  • Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Zitieren

APA

Cocchiararo, I., & Castets, P. (2025). Recent advances in the clinical spectrum and pathomechanisms associated with X-linked myopathy with excessive autophagy and other VMA21 -related disorders. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602251314767

Vancouver

Cocchiararo I, Castets P. Recent advances in the clinical spectrum and pathomechanisms associated with X-linked myopathy with excessive autophagy and other VMA21 -related disorders. Journal of Neuromuscular Diseases. 2025. doi:10.1177/22143602251314767

BibTeX
@article{Cocchiararo2025,
  author = {Cocchiararo, Ilaria and Castets, Perrine},
  title = {Recent advances in the clinical spectrum and pathomechanisms associated with X-linked myopathy with excessive autophagy and other VMA21 -related disorders},
  journal = {Journal of Neuromuscular Diseases},
  year = {2025},
  doi = {10.1177/22143602251314767}
}
Kostenlos starten →